Helen Collins, M.D.
Board Member
IO Biotech, Inc. (IOBTQ)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Helen Collins, M.D.
Helen Collins, M.D. is recorded as Board Member at IO Biotech, Inc. (IOBTQ). IO Biotech, Inc. reported in an 8-K filed November 13, 2023 that Helen Collins, M.D. was appointed Class II director, effective November 9, 2023.
“On November 9, 2023, the Company increased the size of the Board from seven to eight directors, and appointed Helen Collins, M.D. as a Class II director of the Company to fill the vacancy, effective as of that same date.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2023-11-09–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at IO Biotech, Inc.
Other people whose current roles at this company are on record from its filings.
- Amy Sullivan CFO
- Devin W. Smith General Counsel
- Heidi Hunter Board Member
- Mai-Britt Zocca Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.